CD44/HA signaling mediates acquired resistance to a PI3Kα inhibitor

Most luminal breast carcinomas (BrCas) bearing PIK3CA mutations initially respond to phosphoinositide-3-kinase (PI3K)-α inhibitors, but many eventually become resistant. The underlying mechanisms of this resistance remain obscure. In this work, we showed that a CD44(high) state due to aberrant isofo...

Descripción completa

Detalles Bibliográficos
Autores principales: Yang, Cuixia, Sheng, Yumeng, Shi, Xiaoxing, Liu, Yiwen, He, Yiqing, Du, Yan, Zhang, Guoliang, Gao, Feng
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2020
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7538592/
https://www.ncbi.nlm.nih.gov/pubmed/33024087
http://dx.doi.org/10.1038/s41419-020-03037-0

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7538592/
https://www.ncbi.nlm.nih.gov/pubmed/33024087
http://dx.doi.org/10.1038/s41419-020-03037-0

Ejemplares similares